Pliant Therapeutics (PLRX) PT Lowered to $3 at Piper Sandler

March 12, 2026 9:20 AM

Piper Sandler analyst Yasmeen Rahimi lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $3.00 (from $4.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found